Amelot Holdings, Inc. Announces That Its President and CEO, Fred Guarnieri Has Purchased Shares in the Company, Appoints Andrew
18 Junho 2009 - 10:38AM
Marketwired
Amelot Holdings, Inc. (PINKSHEETS: AMHD) announced that its
Corporate attorney, Mr. Andrew Schwab of New York City, has been
appointed as Corporate Secretary.
"I am both pleased and honored to have a man of Andrew's high
caliber on our team," stated Fred Guarnieri, President and CEO.
"Having met with Andrew last week in New York, I can say without
any doubt in my mind he will be a major asset to our Company," Mr.
Guarnieri further added.
After meeting with Mr. Michael Ajzenman of Madison Stock
Transfer in Brooklyn, New York, it was decided that Amelot will
continue its relationship as Transfer Agent. Madison Transfer will
continue to provide information on the Outstanding and authorized
shares of Amelot.
The current Outstanding Common Share balance is 4,309,573,155,
none of which is held by the company. The amount of Common Shares
Authorized is 4,925,000,000
Any officers wishing to sell stock are limited by the" Dribble
Rule" to one percent of the Outstanding Shares per Quarter, or
approximately 43 million shares.
"It is important to have liquidity in the market. As many of you
are aware there hasn't been any over the past six to eight months.
It is my intent to take steps to build investor confidence and
interest, thus providing the liquidity that is needed.
"Therefore, I am pleased to announce that through private
transactions, I have purchased 404,600,000 shares of Amelot
Holdings, Inc.," concluded Fred Guarnieri.
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com), a
publicly traded company, is a diversified holding company that has
identified Biodiesel as a multi-billion emerging Biofuel market.
Amelot plans to have a significant market share in growing low cost
feedstocks to supply the growing demand for biodiesel, to reduce
energy dependency of fossil fuels, to help reduce the U.S.
dependency on foreign oil supplies and reduce the impact of energy
on our environment.
Statements in this press release that are not historical facts
are forward-looking statements within the meaning of the Securities
Act of 1933, as amended. Those statements include statements
regarding the intent, belief or current expectations of the Company
and its management. Such statements reflect management's current
views, are based on certain assumptions and involve risks and
uncertainties. Actual results, events, or performance may differ
materially from the above forward-looking statements due to a
number of important factors, and will be dependent upon a variety
of factors, including, but not limited to, our ability to obtain
additional financing and access funds from our existing financing
arrangements that will allow us to continue our current and future
operations and whether demand for our products and services in
domestic and international markets will continue to expand. The
Company undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that
occur after the date hereof or to reflect any change in the
Company's expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
Contact: Amelot Holdings, Inc. 1(866)-669-8373
support@amelotholdings.com http://www.amelotholdings.com
HLK Biotech (CE) (USOTC:AMHD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
HLK Biotech (CE) (USOTC:AMHD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024